You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
PSO ACTUARIAL RATE MODEL FOR MEDICARE RISK CONTRACTS
SBC: Actuarial Research Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
PSEUDOVIRAL RNA STANDARDS
SBC: AMBION DIAGNOSTICS, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
NOVEL METHOD FOR HIGH-THROUGHPUT MUTATION DETECTION
SBC: AMBION DIAGNOSTICS, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
TECHNOLOGY FOR DETECTION OF NONSENSE MUTATIONS
SBC: AMBION DIAGNOSTICS, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
PRENATAL DIAGNOSIS OF INHERITED BLOOD DISORDERS
SBC: AMERICAN LABORATORY SUPPLIES Topic: N/ADuring pregnancy small numbers of fetal erythrocytes enter the maternal circulation. Among these cells are nucleated erythrocytes called normoblasts. Genomic analysis of these normoblasts using specific probes by in situ hybridization or the polymerase chain reaction (PCR) potentially provides a non-invasive method for diagnosis of genetic defects. Because the number of fetal normoblasts among ...
SBIR Phase I 1997 Department of Health and Human Services -
SELF CARE CUEING DEVICE
SBC: AMRON CORPORATION Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
DETERRENT FOR ESCAPES FROM BED
SBC: AMRON CORPORATION Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
Detection System to identify false medicare claims prior to payment
SBC: Anthem Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
IDENTIFICATION OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGENS
SBC: Argonex, Inc. Topic: N/AIn the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach aimed at the identification of these antigens, termed Direct Identification of Relevant Epitopes for ...
SBIR Phase I 1997 Department of Health and Human Services -
GLUCARATE REDUCTION OF SERUM CHOLESTEROL
SBC: Biochemix, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services